-
Risk of subsequent neoplasms (SNs) after a primary tumor in patients with NF1.
Author(s): Bhatia
Venue: Joint Global Neurofibromatosis Annual Conference
-
Projected improvement in life expectancy across three treatment decades: insights from the Childhood Cancer Survivor Study (CCSS).
Author(s): Yeh
Venue: International Society of Paediatric Oncology Annual Meeting
-
Using the cumulative illness rating scale to characterize the burden of chronic conditions among childhood cancer survivors and to predict mortality.
Author(s): Esbenshade
Venue: International Society of Paediatric Oncology Annual Meeting
-
Hearing impairment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS).
Author(s): Brown
Venue: International Society of Paediatric Oncology Annual Meeting
-
Genome-wide association study to identify obesity susceptibility loci in survivors of childhood Acute Lymphoblastic Leukemia (ALL): a report from the Childhood Cancer Survivor Study (CCSS).
Author(s): Lupo
Venue: International Society of Paediatric Oncology Annual Meeting
-
Social adjustment in adolescent survivors of pediatric CNS tumors: a report from the Childhood Cancer Survivor Study.
Author(s): Schulte
Venue: International Society of Paediatric Oncology Annual Meeting
-
Comparison of radiation dose reconstruction methods to investigate late adverse effects of radiotherapy for childhood cancer: a report from the Childhood Cancer Survivor Study.
Author(s): Schonfeld
Venue: Conference on Radiation and Health Annual Meeting
-
Sleep behaviors and patterns in adult survivors of childhood cancers: a report from the Childhood Cancer Survivor Study (CCSS).
Author(s): Daniel
Venue: Associated Professional Sleep Societies Annual Meeting
-
Prevalence of prescription psychoactive medication use in adolescent survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS).
Author(s): Cheung
Venue: Multinational Association of Supportive Care in Cancer Annual Meeting
-
Pediatric treatment-induced high-grade gliomas are enriched for a specific methylation subgroup and recurrent genomic abnormalities.
Author(s): Lucas
Venue: American Association of Neuropathologists (AANP) Meeting